Drug Information

General Information
Drug ID
DR00511
Drug Name
Cyclothiazide
Synonyms
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-chloro-3-(5-norbornen-2-yl)-, 1,1-dioxide; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-chloro-3-(5-norbornen-2-yl)-,1,1-dioxide; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-bicyclo(2.2.1)hept-5-en-2-yl-6-chloro-3,4-dihydro-, 1,1-dioxide; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-, 1,1-dioxide; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-(5-norbornen-2-yl)-, 1,1-dioxide; 3-(bicyclo[2.2.1]hept-5-en-2-yl)-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 3-Bicyclo(2.2.1)hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2-4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide; 6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-3,4-dihydro-3-(norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-3-(2-norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; Anhydron; Anhydron (TN); Aquirel; C 9847; Ciclotiazida; Ciclotiazida [INN-Spanish]; Ciclotiazide; Ciclotiazide [DCIT]; Cyclothiazide (JAN/USAN/INN); Cyclothiazide [USAN:INN:BAN]; Cyclothiazidum; Cyclothiazidum [INN-Latin]; Doburil; Fluidil; Lilly 35,483; MDi 193; Renazide; Valmiran
Drug Type
Small molecular drug
Therapeutic Class
Antihypertensive Agents
Structure
3D MOL 2D MOL
Formula
C14H16ClN3O4S2
Canonical SMILES
C1C2CC(C1C=C2)C3NC4=CC(=C(C=C4S(=O)(=O)N3)S(=O)(=O)N)Cl
InChI
InChI=1S/C14H16ClN3O4S2/c15-10-5-11-13(6-12(10)23(16,19)20)24(21,22)18-14(17-11)9-4-7-1-2-8(9)3-7/h1-2,5-9,14,17-18H,3-4H2,(H2,16,19,20)
InChIKey
BOCUKUHCLICSIY-UHFFFAOYSA-N
CAS Number
CAS 2259-96-3
Pharmaceutical Properties Molecular Weight 389.9 Topological Polar Surface Area 135
Heavy Atom Count 24 Rotatable Bond Count 2
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 7
XLogP
2
PubChem CID
2910
PubChem SID
103124246 , 103249003 , 104075181 , 104171141 , 104301976 , 10514282 , 11336079 , 11361318 , 11373658 , 11462290 , 11491865 , 117629245 , 121361127 , 124749619 , 124801467 , 124879795 , 124886816 , 127543751 , 134221777 , 17404884 , 24278350 , 26751850 , 29222063 , 46508269 , 47291198 , 47589058 , 47736553 , 47810814 , 48110509 , 48415831 , 49890386 , 50104549 , 50104550 , 50328346 , 53777427 , 56424127 , 57321515 , 583075 , 7413729 , 7848319 , 8149965 , 8151863 , 85085062 , 85230990 , 85787796 , 90341445 , 92303854 , 92307849 , 96079565 , 99301992
TTD Drug ID
D03CNS

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.